232 related articles for article (PubMed ID: 25229990)
1. Antigen-specific active immunotherapy for ovarian cancer.
Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief CJ; Nijman HW
Cochrane Database Syst Rev; 2014 Sep; (9):CD007287. PubMed ID: 25229990
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific active immunotherapy for ovarian cancer.
Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief K; Nijman HW
Cochrane Database Syst Rev; 2010 Jan; (1):CD007287. PubMed ID: 20091627
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific active immunotherapy for ovarian cancer.
Paijens ST; Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief CJ; de Bruyn M; Nijman HW
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD007287. PubMed ID: 30199097
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.
Clarke T; Galaal K; Bryant A; Naik R
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006119. PubMed ID: 25198378
[TBL] [Abstract][Full Text] [Related]
5. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.
Kew F; Galaal K; Bryant A; Naik R
Cochrane Database Syst Rev; 2011 Jun; (6):CD006119. PubMed ID: 21678351
[TBL] [Abstract][Full Text] [Related]
7. The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review).
Oei AL; Sweep FC; Thomas CM; Boerman OC; Massuger LF
Int J Oncol; 2008 Jun; 32(6):1145-57. PubMed ID: 18497976
[TBL] [Abstract][Full Text] [Related]
8. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women.
Chen H; Xiao L; Li J; Cui L; Huang W
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008018. PubMed ID: 30827035
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive T-cell antibody induction for heart transplant recipients.
Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
13. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610
[TBL] [Abstract][Full Text] [Related]
14. Interventions for the treatment of borderline ovarian tumours.
Faluyi O; Mackean M; Gourley C; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD007696. PubMed ID: 20824864
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360
[TBL] [Abstract][Full Text] [Related]
16. Ganoderma lucidum (Reishi mushroom) for cancer treatment.
Jin X; Ruiz Beguerie J; Sze DM; Chan GC
Cochrane Database Syst Rev; 2012 Jun; (6):CD007731. PubMed ID: 22696372
[TBL] [Abstract][Full Text] [Related]
17. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
18. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
Ang C; Chan KK; Bryant A; Naik R; Dickinson HO
Cochrane Database Syst Rev; 2011 Apr; (4):CD007697. PubMed ID: 21491400
[TBL] [Abstract][Full Text] [Related]
19. Specific immunotherapy in ovarian cancer: a systematic review.
Aalipour S; Zoghi S; Khalili N; Hirbod-Mobarakeh A; Emens LA; Rezaei N
Immunotherapy; 2016 Oct; 8(10):1193-204. PubMed ID: 27605068
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.
Abdul Razak AR; Li L; Bryant A; Diaz-Padilla I
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007584. PubMed ID: 21412906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
